Dr. Imran Siddiqi graduated from the University of California Irvine, School of Medicine and completed both his residency and fellowship program at the UCSF. He is specialized in Pathology and board certified in Anatomic & Clinical Pathology and in Hematology. Dr. Siddiqi has been in practice for more than 11 years and is affiliated with the Keck Hospital of USC. During his career, he has also contributed to several publications of clinical interest.
University of California Irvine
American Board of Pathology
Keck Hospital of USC - Medical Center
1500 San Pablo StRead More
Los Angeles Community Hospital
4081 E Olympic BlvdRead More
USC Norris Comprehensive Cancer Center
1441 Eastlake AvenueRead More
Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations.
Siddiqi, I. N.,Friedman, J.,Barry-Holson, K. Q.,Ma, C.,Thodima, V.,Kang, I.,Padmanabhan, R.,Dias, L. M.,Kelly, K. R.,Brynes, R. K.,Kamalakaran, S.,Houldsworth, J.; Mod. Pathol.. 1900 Jan 01.See more >>
Pegylated interferon for the treatment of early myelofibrosis: correlation of serial laboratory studies with response to therapy.
O'Neill, C.,Siddiqi, I.,Brynes, R. K.,Vergara-Lluri, M.,Moschiano, E.,O'Connell, C.; Ann. Hematol.. 1900 Jan 01.See more >>
Cross-platform assessment of genomic imbalance confirms the clinical relevance of genomic complexity and reveals loci with potential pathogenic roles in diffuse large ...
Dias, L. M.,Thodima, V.,Friedman, J.,Ma, C.,Guttapalli, A.,Mendiratta, G.,Siddiqi, I. N.,Syrbu, S.,Chaganti, R. S.,Houldsworth, J.; Leuk. Lymphoma. 2015 Aug 22.See more >>